North American Molecular Diagnostics Market

North American Molecular Diagnostics Market Size, Share, Growth Analysis, By Product(Instruments, Reagents), By Test Location(Point-of-Care (PoC), Self-test or Over the Counter (OTC), Central Laboratories), By Technology(Polymerase Chain Reaction (PCR), Multiplex PCR, Other PCR, In Situ Hybridization), By Application(Oncology, Breast Cancer, Prostate Cancer, Colorectal Cancer), By Regional(The U.S.) - Industry Forecast 2025-2032


Report ID: UCMIR35A2358 | Region: Regional | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Segmentation Analysis:

The North American Molecular Diagnostics Market is segmented by Product, Test Location, Technology, Application, Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

North American Molecular Diagnostics Market Basis Point Share Analysis, 2021 Vs. 2028
BasisPointShareAnalysis
To get detailed analysis on all segments
BUY NOW
  • Based on Product the market is segmented as, Instruments, Reagents
  • Based on Test Location the market is segmented as, Point-of-Care (PoC), Self-test or Over the Counter (OTC), Central Laboratories
  • Based on Technology the market is segmented as, Polymerase Chain Reaction (PCR), Multiplex PCR, Other PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others
  • Based on Application the market is segmented as, Oncology, Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer, Pharmacogenomics, Infectious Diseases, Methicillin-resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Vancomycin-resistant Enterococci (VRE), Carbapenem-resistant Bacteria, Flu, Respiratory Syncytial Virus (RSV), Candida, Tuberculosis and drug-resistant TBA, Meningitis, Gastrointestinal Panel Testing, Chlamydia, Gonorrhea, HIV, Hepatitis C, Hepatitis B, Other Infectious Disease, Genetic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others
  • Based on Regional the market is segmented as, The U.S.
$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for North American Molecular Diagnostics was estimated to be valued at US$ XX Mn in 2021.

The North American Molecular Diagnostics Market is estimated to grow at a CAGR of XX% by 2028.

The North American Molecular Diagnostics Market is segmented on the basis of Product, Test Location, Technology, Application, Regional.

Based on region, the North American Molecular Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the North American Molecular Diagnostics Market are Roche Diagnostics, Qiagen N.V., Danaher, Hologic, Inc., Johnson & Johnson, Becton, Dickinson and Company, Abbott laboratories, bioMérieux SA, Illumina, Inc., Novartis AG, Cepheid, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

North American Molecular Diagnostics Market

Report ID: UCMIR35A2358

$3,500
BUY NOW GET FREE SAMPLE